Esther Fischer
Neurology · Tupelo, MSNPI 1942643747
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,453 and has fallen 93.1% since, to $101 in 2023. That places this record below the midpoint for neurology clinicians in MS, where the typical reported total is $1,546.
Across 97 payments — averaging $18.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$405
- Biohaven Pharmaceutical Holding Company Ltd.$340
- Biogen$177
- Amneal Pharmaceuticals LLC$149
- Livanova USA, Inc.$80
- AstraZeneca$63
- plus $611 from 19 others
What the payments were for
- Speaking & faculty fees$714%
- Food & beverage$1,75496%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 27 | $405 |
| Biohaven Pharmaceutical Holding Company Ltd. | 16 | $340 |
| Biogen | 4 | $177 |
| Amneal Pharmaceuticals LLC | 7 | $149 |
| Livanova USA, Inc. | 1 | $80 |
| AstraZeneca(2 entities) | 5 | $63 |
| Acorda Therapeutics, Inc | 3 | $58 |
| Novartis | 3 | $56 |
| Lundbeck LLC | 3 | $49 |
| Sanofi | 2 | $47 |
| Neurocrine Biosciences, Inc. | 3 | $46 |
| Biohaven Pharmaceuticals, Inc. | 3 | $41 |
| Tanabe Pharma America, Inc. | 2 | $37 |
| Acadia Pharmaceuticals Inc | 2 | $37 |
| Genentech USA, Inc. | 2 | $34 |
| Jazz Pharmaceuticals Inc. | 2 | $30 |
| Avanir Pharmaceuticals, Inc. | 2 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| UCB, Inc. | 2 | $24 |
| Amylyx Pharmaceuticals, Inc. | 1 | $21 |
| Harmony Biosciences LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| EMD Serono, Inc. | 1 | $15 |
| Catalyst Pharmaceuticals, Inc. | 1 | $15 |
| Neurelis, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$103
How this compares
$1,825 in reported general payments places this provider in the 50th percentile of 111 neurology providers in Mississippi.
Other neurology in Tupelo
- Stephen LandyTupelo$1.9M
- Justin GraffTupelo$85K
- Mark FletcherTupelo$41K
- Samuel NewellTupelo$10K
- Donna HarringtonTupelo$6K
- William OakesTupelo$3K
- Ali AhmadTupelo$2K
- Ruth FredericksJackson$943K
- Wendell HelvestonJackson$883K
- Ronald SchwartzHattiesburg$352K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.